# Study of CHS-114 in Participants With Advanced Solid Tumors

> **NCT05635643** · PHASE1 · RECRUITING · sponsor: **Coherus Oncology, Inc.** · enrollment: 87 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** CHS-114
- **DRUG:** toripalimab

## Key facts

- **NCT ID:** NCT05635643
- **Lead sponsor:** Coherus Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-01-01
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635643, "Study of CHS-114 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT05635643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*